Patient Experience Report: Volume 2
The Patient Journey: Discovery, Experience, and Attitudes Towards GLP-1 RAs and SGLT-2 Inhibitors Treatment
What you get
This report includes insights from:-
1,500+ US adults with type 2 diabetes
-
40% non-white participants
-
50% male / 50% female respondents